Radnostix INIS
OTC INIS
$0.04 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Radnostix (INIS) Equity Income (2011 - 2013)

Updated

Radnostix (INIS) posted Equity Income of -$54,463 for FY2012, compared with -$141,642 in FY2011.

Analysis

Radnostix (INIS) Equity Income (2011 - 2013) Analysis & Trends

  • Business Quant data shows INIS's Equity Income at -$141,642 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -19.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Radnostix 20.37 Mn 14.48 Mn 1.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 -2,746.00
Dec 31, 2012 -8,538.00
Sep 30, 2012 -13,943.00
Jun 30, 2012 -5,206.00
Mar 31, 2012 -26,776.00
Dec 31, 2011 -21,945.00
Sep 30, 2011 -43,451.00
Jun 30, 2011 -31,390.00
Mar 31, 2011 -44,856.00
API Access

Radnostix Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=INIS&period=max&api_key=YOUR_API_KEY